FutureHello all.
I have been an RVX stockholder for 10+ years, regularly reading through Stockhouse, Investor Village, and Agoracom comments. My background is risk assessment, including financial and medical. I have gone through the highs and lows along with many of you (never understood how Clevland Clinic got away with their poor performance).
Having read the comments on RVX and Zenith potential, I am surprised by the extremley conservative comments on the valuation of these companies. I would be disappointed if these companies "potential" is in the $3b range. RVX and Zenith are on the verge of setting new insights into medical technology. The medications will touch on an incredible array: cardiovascular, cerebrovascular, neurological, gastro-intestincal, genitourinary. Sales for the top medications can reach $20b U.S., and with patents reaching 15 years, valuations will sky rocket. Net profit is much greater than 50% of yearly new sales, and the potential for 5+ new drug medications over the next 5 years is staggering. My valuation comes into the $100's of billions.
I am not a stock pusher, and have not commented on any other stocks I own. My apologies for what these comments may bring, but others should be aware of the potential of RVX and Zenith.
My opinion only.